1. |
Chen W, Zheng R, Zeng H, et al. Annual report on status of cancer in China, 2011. Chin J Cancer Res, 2015, 27(1): 2-12.
|
2. |
Tachimori Y, Nagai Y, Kanamori N, et al. Pattern of lymph node metastases of esophageal squamous cell carcinoma based on the anatomical lymphatic drainage system. Dis Esophagus, 2011, 24(1): 33-38.
|
3. |
Amin MB, Edge SB, Greene FL, et al. AJCC cancer staging manual. 8th ed. New York: Springer, 2017. 185-202.
|
4. |
Gockel I, Sgourakis G, Lyros O, et al. Dissection of lymph node metastases in esophageal cancer. Expert Rev Anticancer Ther, 2011, 11(4): 571-578.
|
5. |
Rice TW, Blackstone EH, Adelstein DJ, et al. N1 esophageal carcinoma: The importance of staging and downstaging. J Thorac Cardiovasc Surg, 2001, 121(3): 454-464.
|
6. |
Hagens ERC, van Berge Henegouwen MI, Gisbertz SS. Distribution of lymph node metastases in esophageal carcinoma patients undergoing upfront surgery: A systematic review. Cancers (Basel), 2020, 12(6): 1592.
|
7. |
Hsu PK, Huang CS, Hsieh CC, et al. Role of right upper mediastinal lymph node metastasis in patients with esophageal squamous cell carcinoma after tri-incisional esophagectomies. Surgery, 2014, 156(5): 1269-1277.
|
8. |
Guo X, Mao T, Gu Z, et al. Clinical study on postoperative recurrence in patients with pN1 esophageal squamous cell carcinoma. Thorac Cancer, 2015, 6(2): 146-150.
|
9. |
Kikuchi H, Takeuchi H. Future perspectives of surgery for esophageal cancer. Ann Thorac Cardiovasc Surg, 2018, 24(5): 219-222.
|
10. |
Bollschweiler E, Plum P, Mönig SP, et al. Current and future treatment options for esophageal cancer in the elderly. Expert Opin Pharmacother, 2017, 18(10): 1001-1010.
|
11. |
Malassagne B, Tiret E, Duprez D, et al. Prognostic value of thoracic recurrent nerve nodal involvement in esophageal squamous cell carcinoma. J Am Coll Surg, 1997, 185(3): 244-249.
|
12. |
王镇, 柳硕岩. 食管胸中段鳞癌喉返神经旁淋巴结清扫的临床价值. 中华胃肠外科杂志, 2015, 18(9): 867-870.
|
13. |
Liu JG, Hu Y, Xie X, et al. Subcarinal node metastasis in thoracic esophageal squamous cell carcinoma. Ann Thorac Surg, 2012, 93(2): 423-427.
|
14. |
Matsubara T, Ueda M, Abe T, et al. Unique distribution patterns of metastatic lymph nodes in patients with superficial carcinoma of the thoracic oesophagus. Br J Surg, 1999, 86(5): 669-673.
|
15. |
Feng JF, Zhao Q, Chen QX. Prognostic value of subcarinal lymph node metastasis in patients with esophageal squamous cell carcinoma. Asian Pac J Cancer Prev, 2013, 14(5): 3183-3186.
|
16. |
Matsubara T, Ueda M, Kaisaki S, et al. Localization of initial lymph node metastasis from carcinoma of the thoracic esophagus. Cancer, 2000, 89(9): 1869-1873.
|
17. |
Igaki H, Tachimori YJ, Kato H. Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection. Ann Surg, 2004, 239(4): 483-490.
|
18. |
Liu J, Liu Q, Wang Y, et al. Nodal skip metastasis is associated with a relatively poor prognosis in thoracic esophageal squamous cell carcinoma. Eur J Surg Oncol, 2016, 42(8): 1202-1205.
|
19. |
Prenzel KL, Bollschweiler E, Schröder W, et al. Prognostic relevance of skip metastases in esophageal cancer. Ann Thorac Surg, 2010, 90(5): 1662-1667.
|